Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.47 USD
0.47%
Market Closed
Updated:
Apr 27, 2024
Prestige Consumer Healthcare Inc
Interest Income Expense
|
Prestige Consumer Healthcare Inc
Interest Income Expense Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Interest Income Expense
-$70.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
0%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Interest Income Expense
$178m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Interest Income Expense
-$877m
|
CAGR 3-Years
-131%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Interest Income Expense
$2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Interest Income Expense
-$811m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Interest Income Expense
-$332.5m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-23%
|
See Also
What is Prestige Consumer Healthcare Inc's Interest Income Expense?
Interest Income Expense
-70.9m
USD
-70.9m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Interest Income Expense amounts to -70.9m USD.
What is Prestige Consumer Healthcare Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
0%
0%
Over the last year, the Interest Income Expense growth was -7%. The average annual Interest Income Expense growth rates for Prestige Consumer Healthcare Inc have been 6% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
